153 related articles for article (PubMed ID: 38490708)
1. Nodular lesions of the buttock for 20 years: the challenge of chromoblastomycosis in non-endemic settings.
Osborne W; Langman G; Ladoyanni E; Chue A
BMJ Case Rep; 2024 Mar; 17(3):. PubMed ID: 38490708
[TBL] [Abstract][Full Text] [Related]
2. [Chromomycosis acquired in a non-tropical area: A case report].
Ouédraogo MS; Vignon-Pennamen MD; Battistella M; Levy A; Feuilhade de Chauvin M; Petit A
Ann Dermatol Venereol; 2017; 144(6-7):438-442. PubMed ID: 28396061
[TBL] [Abstract][Full Text] [Related]
3. An impressive case of chromoblastomycosis due to Fonsecaea pedrosoi in a patient with a long history of fungal infection.
Romero-Navarrete M; Ruíz LF; Castillo A; Arenas R; Vega-Memije ME; Xicohtencatl-Cortes J; Espinoza-Rivera M; Hernández-Castro R
J Mycol Med; 2018 Dec; 28(4):663-665. PubMed ID: 30126716
[TBL] [Abstract][Full Text] [Related]
4. Chromoblastomycosis: clinical experience and review of literature.
Queiróz AJR; Pereira Domingos F; Antônio JR
Int J Dermatol; 2018 Nov; 57(11):1351-1355. PubMed ID: 30113072
[TBL] [Abstract][Full Text] [Related]
5. Chromoblastomycosis in the Amazon region, Brazil, caused by Fonsecaea pedrosoi, Fonsecaea nubica, and Rhinocladiella similis: Clinicopathology, susceptibility, and molecular identification.
de Andrade TS; de Almeida AMZ; Basano SA; Takagi EH; Szeszs MW; Melhem MSC; Albuquerque M; Camargo JSAA; Gambale W; Camargo LMA
Med Mycol; 2020 Feb; 58(2):172-180. PubMed ID: 31329924
[TBL] [Abstract][Full Text] [Related]
6. Photodynamic therapy combined with antifungal drugs against chromoblastomycosis and the effect of ALA-PDT on Fonsecaea in vitro.
Hu Y; Qi X; Sun H; Lu Y; Hu Y; Chen X; Liu K; Yang Y; Mao Z; Wu Z; Zhou X
PLoS Negl Trop Dis; 2019 Oct; 13(10):e0007849. PubMed ID: 31671098
[TBL] [Abstract][Full Text] [Related]
7. Photodynamic therapy combined with terbinafine against chromoblastomycosis and the effect of PDT on Fonsecaea monophora in vitro.
Hu Y; Huang X; Lu S; Hamblin MR; Mylonakis E; Zhang J; Xi L
Mycopathologia; 2015 Feb; 179(1-2):103-9. PubMed ID: 25366276
[TBL] [Abstract][Full Text] [Related]
8. Chromoblastomycosis.
Torres-Guerrero E; Isa-Isa R; Isa M; Arenas R
Clin Dermatol; 2012; 30(4):403-8. PubMed ID: 22682188
[TBL] [Abstract][Full Text] [Related]
9. Antifungal therapy in an athymic murine model of chromoblastomycosis by Fonsecaea pedrosoi.
Calvo E; Pastor FJ; Mayayo E; Hernández P; Guarro J
Antimicrob Agents Chemother; 2011 Aug; 55(8):3709-13. PubMed ID: 21576429
[TBL] [Abstract][Full Text] [Related]
10. Chromoblastomycosis: an overview of clinical manifestations, diagnosis and treatment.
Queiroz-Telles F; Esterre P; Perez-Blanco M; Vitale RG; Salgado CG; Bonifaz A
Med Mycol; 2009 Feb; 47(1):3-15. PubMed ID: 19085206
[TBL] [Abstract][Full Text] [Related]
11. Chromoblastomycosis due to Fonsecaea monophora in a man with nephritic syndrome.
Tan H; Xu Y; Lan XM; Wu YG; Zhou CJ; Yang XC
Mycopathologia; 2015 Jun; 179(5-6):447-52. PubMed ID: 25575792
[TBL] [Abstract][Full Text] [Related]
12. A case of chromoblastomycosis by Fonsecaea nubica indicating a possible insect route of transmission.
Chen Y; Yin S; Li M; Chen R; Wei L; Ma H; Deng S; de Hoog GS; Lai W; Lu C; Feng P
Mycoses; 2016 Oct; 59(10):662-7. PubMed ID: 27330038
[TBL] [Abstract][Full Text] [Related]
13. Chromoblastomycosis caused by Fonsecaea: clinicopathology, susceptibility and molecular identification of seven consecutive cases in Southern China.
Yang YP; Li W; Huang WM; Zhou Y; Fan YM
Clin Microbiol Infect; 2013 Nov; 19(11):1023-8. PubMed ID: 23153454
[TBL] [Abstract][Full Text] [Related]
14. [Fonsecaea pedrosoi-induced chromoblastomycosis: about a case].
Baline K; Hali F
Pan Afr Med J; 2018; 30():187. PubMed ID: 30455816
[TBL] [Abstract][Full Text] [Related]
15. A case of relapsed chromoblastomycosis due to Fonsecaea monophora: antifungal susceptibility and phylogenetic analysis.
Daboit TC; Magagnin CM; Heidrich D; Castrillón MR; Mendes SD; Vettorato G; Valente P; Scroferneker ML
Mycopathologia; 2013 Aug; 176(1-2):139-44. PubMed ID: 23645135
[TBL] [Abstract][Full Text] [Related]
16. New possibilities for chromoblastomycosis and phaeohyphomycosis treatment: identification of two compounds from the MMV Pathogen Box® that present synergism with itraconazole.
Coelho RA; Alves GM; Figueiredo-Carvalho MHG; Almeida-Silva F; de Souza GR; Lourenço MCDS; Brito-Santos F; Amaral ACF; Almeida-Paes R
Mem Inst Oswaldo Cruz; 2022; 117():e220089. PubMed ID: 36102413
[TBL] [Abstract][Full Text] [Related]
17. Successful treatment of chromoblastomycosis of 36 years duration caused by Fonsecaea monophora.
Najafzadeh MJ; Rezusta A; Cameo MI; Zubiri ML; Yus MC; Badali H; Revillo MJ; De Hoog GS
Med Mycol; 2010 Mar; 48(2):390-3. PubMed ID: 19488919
[TBL] [Abstract][Full Text] [Related]
18. Molecular epidemiology and clinical-laboratory aspects of chromoblastomycosis in Mato Grosso, Brazil.
Guevara A; Nery AF; de Souza Carvalho Melhem M; Bonfietti L; Rodrigues AM; Hagen F; de Carvalho JA; de Camargo ZP; de Souza Lima BJF; Vicente VA; Hahn RC
Mycoses; 2022 Dec; 65(12):1146-1158. PubMed ID: 35869803
[TBL] [Abstract][Full Text] [Related]
19. Cyphellophora laciniata: A new etiological agent of chromoblastomycosis.
León-Lara X; Atoche C; Arenas R; Martínez-Hernández F; Martínez-Chavarría LC; Xicohtencatl-Cortes J; Vázquez-Aceituno VA; Hernández-Castro R
J Mycol Med; 2022 Mar; 32(1):101204. PubMed ID: 34598111
[TBL] [Abstract][Full Text] [Related]
20. Right buttock rash for thirty years in a patient from China.
Pho MT; Burgin S
Clin Infect Dis; 2009 Aug; 49(3):432, 477-8. PubMed ID: 19586395
[No Abstract] [Full Text] [Related]
[Next] [New Search]
